A Highly Sensitive Urinary Exosomal miRNAs Biosensor Applied to Evaluation of Prostate Cancer Progression

Prostate cancer is the most common cancer in the male population, carrying a significant disease burden. PSA is a widely available screening tools for this disease. Current screen-printed carbon electrode (SPCE)-based biosensors use a two-pronged probe approach to capture urinary miRNA. We were able...

Full description

Bibliographic Details
Main Authors: Yueh-Er Chiou, Kai-Jie Yu, Sow-Neng Pang, Yan-Lin Yang, See-Tong Pang, Wen-Hui Weng
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Bioengineering
Subjects:
Online Access:https://www.mdpi.com/2306-5354/9/12/803
_version_ 1797461414619643904
author Yueh-Er Chiou
Kai-Jie Yu
Sow-Neng Pang
Yan-Lin Yang
See-Tong Pang
Wen-Hui Weng
author_facet Yueh-Er Chiou
Kai-Jie Yu
Sow-Neng Pang
Yan-Lin Yang
See-Tong Pang
Wen-Hui Weng
author_sort Yueh-Er Chiou
collection DOAJ
description Prostate cancer is the most common cancer in the male population, carrying a significant disease burden. PSA is a widely available screening tools for this disease. Current screen-printed carbon electrode (SPCE)-based biosensors use a two-pronged probe approach to capture urinary miRNA. We were able to successfully detect specific exosomal miRNAs (exomiRs) in the urine of patients with prostate cancer, including exomiR-451 and exomiR-21, and used electrochemistry for measurement and analysis. Our results significantly reaffirmed the presence of exomiR-451 in urine and that a CV value higher than 220 nA is capable of identifying the presence of disease (<i>p</i>-value = 0.005). Similar results were further proven by a PAS greater than 4 (<i>p</i>-value = 0.001). Moreover, a higher urinary exomiR-21 was observed in the high-T3b stage; this significantly decreased following tumor removal (<i>p</i>-values were 0.016 and 0.907, respectively). According to analysis of the correlation with tumor metastasis, a higher exomiR-21 was associated with lymphatic metastasis (p-value 0.042), and higher exomiR-461 expression was correlated with tumor stage (<i>p</i>-value 0.031), demonstrating that the present exomiR biosensor can usefully predict tumor progression. In conclusion, this biosensor represents an easy-to-use, non-invasive screening tool that is both sensitive and specific. We strongly believe that this can be used in conjunction with PSA for the screening of prostate cancer.
first_indexed 2024-03-09T17:19:06Z
format Article
id doaj.art-49f613c5280c4ee6bb55167dacbc70ef
institution Directory Open Access Journal
issn 2306-5354
language English
last_indexed 2024-03-09T17:19:06Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Bioengineering
spelling doaj.art-49f613c5280c4ee6bb55167dacbc70ef2023-11-24T13:21:18ZengMDPI AGBioengineering2306-53542022-12-0191280310.3390/bioengineering9120803A Highly Sensitive Urinary Exosomal miRNAs Biosensor Applied to Evaluation of Prostate Cancer ProgressionYueh-Er Chiou0Kai-Jie Yu1Sow-Neng Pang2Yan-Lin Yang3See-Tong Pang4Wen-Hui Weng5Department of Nursing, College of Medicine, Fu Jen Catholic University, New Taipei City 242, TaiwanDepartment of Chemical Engineering and Biotechnology and Graduate Institute of Biochemical and Biomedical Engineering, National Taipei University of Technology, Taipei City 106, TaiwanDepartment of Emergency Medicine, Monash Medical Centre, Melbourne, VIC 3083, AustraliaDepartment of Chemical Engineering and Biotechnology and Graduate Institute of Biochemical and Biomedical Engineering, National Taipei University of Technology, Taipei City 106, TaiwanDivision of Urology, Department of Surgery, Chang Gung Memorial Hospital, Taoyuan 33305, TaiwanDepartment of Chemical Engineering and Biotechnology and Graduate Institute of Biochemical and Biomedical Engineering, National Taipei University of Technology, Taipei City 106, TaiwanProstate cancer is the most common cancer in the male population, carrying a significant disease burden. PSA is a widely available screening tools for this disease. Current screen-printed carbon electrode (SPCE)-based biosensors use a two-pronged probe approach to capture urinary miRNA. We were able to successfully detect specific exosomal miRNAs (exomiRs) in the urine of patients with prostate cancer, including exomiR-451 and exomiR-21, and used electrochemistry for measurement and analysis. Our results significantly reaffirmed the presence of exomiR-451 in urine and that a CV value higher than 220 nA is capable of identifying the presence of disease (<i>p</i>-value = 0.005). Similar results were further proven by a PAS greater than 4 (<i>p</i>-value = 0.001). Moreover, a higher urinary exomiR-21 was observed in the high-T3b stage; this significantly decreased following tumor removal (<i>p</i>-values were 0.016 and 0.907, respectively). According to analysis of the correlation with tumor metastasis, a higher exomiR-21 was associated with lymphatic metastasis (p-value 0.042), and higher exomiR-461 expression was correlated with tumor stage (<i>p</i>-value 0.031), demonstrating that the present exomiR biosensor can usefully predict tumor progression. In conclusion, this biosensor represents an easy-to-use, non-invasive screening tool that is both sensitive and specific. We strongly believe that this can be used in conjunction with PSA for the screening of prostate cancer.https://www.mdpi.com/2306-5354/9/12/803prostate cancerSPCEmicroRNAbiosensor
spellingShingle Yueh-Er Chiou
Kai-Jie Yu
Sow-Neng Pang
Yan-Lin Yang
See-Tong Pang
Wen-Hui Weng
A Highly Sensitive Urinary Exosomal miRNAs Biosensor Applied to Evaluation of Prostate Cancer Progression
Bioengineering
prostate cancer
SPCE
microRNA
biosensor
title A Highly Sensitive Urinary Exosomal miRNAs Biosensor Applied to Evaluation of Prostate Cancer Progression
title_full A Highly Sensitive Urinary Exosomal miRNAs Biosensor Applied to Evaluation of Prostate Cancer Progression
title_fullStr A Highly Sensitive Urinary Exosomal miRNAs Biosensor Applied to Evaluation of Prostate Cancer Progression
title_full_unstemmed A Highly Sensitive Urinary Exosomal miRNAs Biosensor Applied to Evaluation of Prostate Cancer Progression
title_short A Highly Sensitive Urinary Exosomal miRNAs Biosensor Applied to Evaluation of Prostate Cancer Progression
title_sort highly sensitive urinary exosomal mirnas biosensor applied to evaluation of prostate cancer progression
topic prostate cancer
SPCE
microRNA
biosensor
url https://www.mdpi.com/2306-5354/9/12/803
work_keys_str_mv AT yueherchiou ahighlysensitiveurinaryexosomalmirnasbiosensorappliedtoevaluationofprostatecancerprogression
AT kaijieyu ahighlysensitiveurinaryexosomalmirnasbiosensorappliedtoevaluationofprostatecancerprogression
AT sownengpang ahighlysensitiveurinaryexosomalmirnasbiosensorappliedtoevaluationofprostatecancerprogression
AT yanlinyang ahighlysensitiveurinaryexosomalmirnasbiosensorappliedtoevaluationofprostatecancerprogression
AT seetongpang ahighlysensitiveurinaryexosomalmirnasbiosensorappliedtoevaluationofprostatecancerprogression
AT wenhuiweng ahighlysensitiveurinaryexosomalmirnasbiosensorappliedtoevaluationofprostatecancerprogression
AT yueherchiou highlysensitiveurinaryexosomalmirnasbiosensorappliedtoevaluationofprostatecancerprogression
AT kaijieyu highlysensitiveurinaryexosomalmirnasbiosensorappliedtoevaluationofprostatecancerprogression
AT sownengpang highlysensitiveurinaryexosomalmirnasbiosensorappliedtoevaluationofprostatecancerprogression
AT yanlinyang highlysensitiveurinaryexosomalmirnasbiosensorappliedtoevaluationofprostatecancerprogression
AT seetongpang highlysensitiveurinaryexosomalmirnasbiosensorappliedtoevaluationofprostatecancerprogression
AT wenhuiweng highlysensitiveurinaryexosomalmirnasbiosensorappliedtoevaluationofprostatecancerprogression